Seminars in Oncology Nursing
Volume 23, Issue 3 , Pages 232-239 , August 2007

Clinical Dilemmas: Vascular Access Devices

  • Dawn Camp-Sorrell

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dawn Camp-Sorrell, MSN, FNP, AOCN©, 274 Baron Drive, Chelsea, AL 35043

References 

  1. Camp-Sorrell D. Access device guidelines. Recommendations for nursing practice and education. Ed 2. Pittsburgh, PA: Oncology Nursing Society; 2004;
  2. Conly JM, Grieves K, Peters B. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis. 1989;159:310–319
  3. Petrosino B, Becker H, Christian B. Infection rates in central venous catheter dressings. Oncol Nurs Forum. 1988;15:709–717
  4. Dickerson N, Horton P, Smith S, et al. Clinically significant central venous catheter infections in a community hospital: association with type of dressing. J Infect Dis. 1989;160:720–721
  5. Shivnan JC, McGuire D, Freedman S, et al. A comparison of transparent adherent and dry sterile gauze dressings for long-term central catheters in patients undergoing bone marrow transplants. Oncol Nurs Forum. 1991;18:1349–1355
  6. Engervall P, Ringertz S, Hagman E, et al. Change of central venous catheter dressings twice a week is superior to once a week in patients with hematological malignancies. J Hosp Infect. 1995;29:275–286
  7. Brandt B, DePalma J, Irwin M, et al. Comparisons of central venous catheter dressings in bone marrow transplant recipients. Oncol Nurs Forum. 1996;23:829–836
  8. Olson K, Rennie RP, Hanson J, et al. Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites. J Infus Nurs. 2004;27:37–44
  9. Hoffmann KK, Weber DJ, Samsa GP, et al. Transparent polyurethane film as an intravenous catheter dressing (A meta-analysis of the infection risks). JAMA. 1992;267:2072–2076
  10. Gillies D, O’Riordan E, Carr D, et al. Central venous catheter dressings: a systematic review. J Adv Nurs. 2003;44:623–632
  11. Laura R, Degl’Innocenti M, Mocali M, et al. Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized, multicenter study. The Italian nurse bone marrow transplant group (GITMO) Haematologica. 2000;85:275–279
  12. Centers for Disease Control and Prevention. Guidelines for prevention of intravascular catheter-related infections. MMWR Morbid Mortal Weekly Rep. 2002;51:1–29
  13. Mermel LA, Farr BM, Sheretz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249–1272
  14. Jones PM. Indwelling central venous catheter-related infections and two different procedures of catheter care. Cancer Nurs. 1987;10:123–130
  15. Maki DG, Ringer M, Alvarado C. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–343
  16. Chaiyakunapruk N, Veenstra DL, Lipsky BA, et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter site care: a meta analysis. Ann Intern Med. 2002;136:792–801
  17. Petersen FY, Kirchhoff KT. Analysis of research about heparinized versus nonheparinized intravascular lines. Heart Lung. 1991;20:631–642
  18. Kelly C, Dumenko L, McGregor SE, et al. A change in flushing protocols of central venous catheters. Oncol Nurs Forum. 1992;19:599–605
  19. Masoorli S, Angeles T. Results from 1993 venous access device patency survey. NAVAN. 1994;1:12–14
  20. Stephens L, Haire W, Tarantolo S, et al. Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells. Transfusion Science. 1997;18:187–193
  21. Kuo YS, Schwartz B, Santiago J, et al. How often should a port-a-cath be flushed?. Cancer Invest. 2005;23:582–585
  22. Keller CA. Methods of drawing blood samples through central venous catheters in pediatric patients undergoing bone marrow transplant: results of a national survey. Oncol Nurs Forum. 1994;21:879–884
  23. Cosca P, Smith S, Chatfield S, et al. Reinfusion of discard blood from venous access devices. Oncol Nurs Forum. 1998;25:1073–1076
  24. Hinds PS, Quargnenti A, Gattuso J, et al. Comparing the results of coagulation tests on blood drawn by venipuncture and through heparinized tunneled venous access devices in pediatric patients with cancer. Oncol Nurs Forum. 2002;29:E26–E34
  25. Penwarden LM, Montgomery PG. Developing a protocol for obtaining blood cultures from central venous catheter and peripheral sites. Clin J Oncol Nurs. 2002;6:268–270
  26. Chatzinikolaou I, Hanna H, Darouiche R, et al. Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and blood stream infection. J Clin Micro. 2006;44:1834–1835
  27. Moran AB, Camp-Sorrell D. Maintenance of venous access devices in patients with neutropenia. Clin J Oncol Nurs. 2002;6:126–130
  28. Bestul MB, VandenBussche HL. Antibiotic lock technique: review of the literature. Pharmacotherapy. 2005;25:211–227
  29. Schwartz C, Henrickson KJ, Roghmann K, et al. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol. 1990;8:1591–1597
  30. Barriga FJ, Varas M, Potin M, et al. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Med Pediatr Oncol. 1997;28:196–200
  31. Anthony TU, Rubin LG. Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother. 1999;43:2074–2076
  32. Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized double blind trial of an antibiotic lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother. 1999;43:2200–2204
  33. Haimi-Cohen Y, Husain N, Meenan J, et al. Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: Simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents Chemother. 2001;45:1565–1567
  34. Reimund JM, Arondel Y, Finck G, et al. Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey. Clin Nutr. 2002;21:33–38
  35. Rackoff WR, Weiman M, Jakobowski D, et al. a randomized, Controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr. 1994;127:147–151
  36. Daghistani D, Horn M, Rodriguez Z, et al. Prevention of indwelling central venous catheter sepsis. Med Pediatr Oncol. 1996;26:405–408
  37. Timoney JP, Malkin DM, Leone JS, et al. Safe and cost effective use of alteplase for clearance of occluded central venous access devices. J Clin Oncol. 2002;20:1918–1922
  38. Semba CP, Deitcher SR, Li X, et al. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients. J Vasc Interv Radiol. 2002;13:1199–1205
  39. Linenberger ML. Catheter-related thrombosis: risks, diagnosis, and management. J Natl Comp Cancer Net. 2006;4:889–901
  40. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21:3665–3675
  41. Baarslag HJ, Koopman MM, Reekers JA, et al. Diagnosis and management of deep venous thrombosis of the upper extremity: a review. Eur Radiol. 2004;14:1263–1274
  42. Rooden CT, Tesselaar ME, Osanto S, et al. Deep venous thrombosis associated with central venous catheters–a review. J Thromb Haemost. 2005;3:2409–2419
  43. Lee AY, Levine MN, Butler G, et al. Incidence, risk factors and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol. 2006;24:1404–1408
  44. Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: Pathophysiology, diagnosis, and management. Hematol Oncol Clin North Am. 2005;19:183–202
  45. Bernardi E, Pesavento R, Prandoni P. Upper extremity deep venous thrombosis. Semin Thromb Hemost. 2006;32:729–736
  46. Boraks P, Seale J, Price J, et al. Prevention of central venous catheter-associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Hematol. 1998;101:483–486
  47. Mokrzycki MH, Jean-Jerome D, Rush H, et al. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters. Kidney Int. 2001;59:1935–1942
  48. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters (A randomized prospective trial). Ann Intern Med. 1990;112:423–428
  49. Heaton DC, Han DY, Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J. 2002;32:84–88
  50. Couban S, Goodyear M, Burnell M, et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol. 2005;23:4603–4069
  51. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thrombolism (The seventh ACCP conference on antithrombotic and thrombolytic therapy). Chest. 2004;126(suppl 3):338S–400S
  52. Biffi R, de Braud F, Orsi F, et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer. 2001;92:1204–1212
  53. Biffi R, Corrado F, de Braud F, et al. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Eur J Cancer. 1997;33:1190–1194
  54. Pasquale MD, Campbell JM, Malignant CM. Groshong versus Hickman catheters. Surg Gynecol Obstet. 1992;174:408–410
  55. Lamont JP, McCarty TM, Stephens JS, et al. A randomized trial of valved vs nonvalved implantable ports for vascular access. BUMC Proc. 2003;16:384–387
  56. Schulmeister L, Camp-Sorrell D. Chemotherapy extravasations from implanted ports. Oncol Nurs Forum. 2000;27:531–538

PII: S0749-2081(07)00058-7

doi: 10.1016/j.soncn.2007.05.008

Seminars in Oncology Nursing
Volume 23, Issue 3 , Pages 232-239 , August 2007

Article Tools